Following positive clinical data , retatrutide, a novel peptide therapy for treating non-insulin dependent metabolic disorder, has secured conditional approval from the Drug and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/